Nothing Special   »   [go: up one dir, main page]

PT3613739T - Integrin antagonists - Google Patents

Integrin antagonists

Info

Publication number
PT3613739T
PT3613739T PT191924026T PT19192402T PT3613739T PT 3613739 T PT3613739 T PT 3613739T PT 191924026 T PT191924026 T PT 191924026T PT 19192402 T PT19192402 T PT 19192402T PT 3613739 T PT3613739 T PT 3613739T
Authority
PT
Portugal
Prior art keywords
integrin antagonists
integrin
antagonists
Prior art date
Application number
PT191924026T
Other languages
Portuguese (pt)
Original Assignee
Oxurion NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxurion NV filed Critical Oxurion NV
Publication of PT3613739T publication Critical patent/PT3613739T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT191924026T 2018-09-13 2019-08-19 Integrin antagonists PT3613739T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18194258 2018-09-13

Publications (1)

Publication Number Publication Date
PT3613739T true PT3613739T (en) 2020-12-09

Family

ID=63579186

Family Applications (1)

Application Number Title Priority Date Filing Date
PT191924026T PT3613739T (en) 2018-09-13 2019-08-19 Integrin antagonists

Country Status (4)

Country Link
EA (1) EA202190428A1 (en)
HR (1) HRP20201912T1 (en)
MA (1) MA51342B1 (en)
PT (1) PT3613739T (en)

Also Published As

Publication number Publication date
EA202190428A1 (en) 2021-06-21
MA51342A (en) 2020-02-26
MA51342B1 (en) 2020-12-31
HRP20201912T1 (en) 2021-01-22

Similar Documents

Publication Publication Date Title
SG11202101913PA (en) INHIBITING aV ß6 INTEGRIN
ZA202101406B (en) Integrin antagonists
EP3860977A4 (en) Integrin antagonists
SG11201609614QA (en) α4β7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS
RS62317B1 (en) Trpv4 antagonists
EP3481814A4 (en) Tetrahydronaphthyridinepentanamide integrin antagonists
GB201717974D0 (en) Modified receptors
GB201905552D0 (en) Antagonists
IL267686A (en) Integrin antagonists
IL274751A (en) Ildr2 antagonists and combinations thereof
IL292692A (en) Mrgprx2 antagonists and uses thereof
SG11202002207QA (en) Trpv2 antagonists
GB201815629D0 (en) Antagonists
GB201820458D0 (en) Ox1 antagonists
IL292693A (en) Mrgprx2 antagonists and uses thereof
PT3613739T (en) Integrin antagonists
GB201718256D0 (en) Ox1 antagonists
IL283413A (en) Antagonists
GB201707499D0 (en) Orexin receptor antagonists
GB201702174D0 (en) Orexin receptor antagonists
ZA201807767B (en) Angiotensin-1-receptor antagonists
GB201908621D0 (en) Construction set
PT3464324T (en) Angiotensin-1-receptor antagonists
GB201719750D0 (en) Local area network
GB201714295D0 (en) New pharamaceutical use